Baylor University
Waco, Texas, 76798, United States
Location status: Recruiting
Location contact
Antonia Silva, DPT
CONTACT
Elizabeth Ardolino, PT, PhD
CONTACT
NCT Number: NCT07280923
This study is testing the psychometric properties of a new tool to determine recommendations for pressure relief frequency in wheelchair users.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Waco, Texas, 76798, United States
Location status: Recruiting
Antonia Silva, DPT
CONTACT
Elizabeth Ardolino, PT, PhD
CONTACT
The goal of the proposed study is to establish the content validity and inter-rater reliability of a new tool, the Pressure Relief Frequency Scale (PReFS). Findings from this study will provide clinicians with a tool that can be used to develop an individualized approach to teaching patients how frequently to perform weight shifts. The part of the study will establish the inter-rater reliability of the PReFs through video recordings of individuals who are wheelchair users.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be interviewed for this study. No intervention will occur.
Time frame: Baseline
Each participant will take part in a 10-minute interview to answer questions on the PReFS
Contact information is provided by the study sponsor or research team.
Antonia Silva, DPT
CONTACT
Elizabeth Ardolino, PT, PhD
CONTACT
Baylor University
Other
Reliability and Validity of the Pressure Relief Frequency Scale
Acronym: PReFS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02795052
ALS, Alzheimer Disease
Westport, Connecticut, United States
View Trial DetailsNCT07521384
Alzheimer Dementia (AD), Alzheimer Disease
Monterrey, Nuevo León, Mexico
View Trial DetailsNCT00060541
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00271622
Autism, Autism Spectrum Disorder
Bethesda, Maryland, United States
View Trial Details